there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have been shown to correlate with ...

RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

We survived the nightmare of watching our son battle RSV in the pediatric ICU. It never occurred to us that we'd later have to worry about measles with our daughter.

For example, Pfizer (NYSE: PFE) launched its RSV vaccine, Abrysvo ... Finally, this could be a lousy time to invest in a ...

GSK to showcase latest research at the International RSV Symposium to advance RSV prevention in adults: London, UK Saturday, March 8, 2025, 14:00 Hrs [IST] GSK plc will share its ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...

At the postponed meeting, the panel was scheduled to discuss a new meningitis vaccine, a shot targeting the mosquito-borne Chikungunya virus, along with RSV and influenza shots. 19,000.